Liquid biopsy has emerged as a promising tool for assessing minimal residual disease (MRD) in lymphoma. Unlike traditional tissue biopsies, which are complex, liquid biopsy analyzes biomarkers present in bodily fluids https://estelleajnf774532.wikiexpression.com/user